• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

VC Firm General Catalyst Partners Lands First NHS Trust Partnership in UK

Share:

September 27, 2022

What You Should Know:

– Venture capital firm General Catalyst announced a partnership with Guy’s and St Thomas’ NHS Foundation Trust (GSTT), the largest hospital system in the UK with a diverse patient population and a longstanding commitment to innovation.

– As part of the partnership, General Catalyst and GSTT will work together to identify innovative digital solutions that benefit patients and providers by addressing problems such as hospital capacity constraints, long wait times and staff shortages. Through this partnership, GSTT will have access to General Catalyst’s deep network of Health Assurance companies.

– General Catalyst’s Health Assurance vision is to partner with the healthcare industry to create a more patient-focussed, proactive healthcare designed to help people stay well,, and make quality care more efficient, affordable and accessible to all. This collaboration between General Catalyst, Guy’s and St Thomas’ and KHP Ventures underscores their alignment with the Health Assurance vision.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Centene and CVS Health Announce Agreement for CVS Health to Acquire IlliniCare HealthCentene and CVS Health Announce Agreement for CVS Health to Acquire IlliniCare Health
  • No, A.I. Won’t Worsen Health Disparities But It May Safeguard the Doctor-Patient RelationshipNo, A.I. Won’t Worsen Health Disparities But It May Safeguard the Doctor-Patient Relationship
  • Todos Medical Enters Into Binding Agreement to Acquire all 3CL Protease Biology-Related Assets and Intellectual Property from NLC PharmaTodos Medical Enters Into Binding Agreement to Acquire all 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma
  • ZyVersa Therapeutics, Inc. Announces Pricing of $5.0 Million Public OfferingZyVersa Therapeutics, Inc. Announces Pricing of $5.0 Million Public Offering
  • Syncona to Acquire Applied Genetic Technologies CorporationSyncona to Acquire Applied Genetic Technologies Corporation
  • Irish software startup nabs $25M Series C to speed up clinical trialsIrish software startup nabs $25M Series C to speed up clinical trials
  • Exo Looks to Commercialize Its Handheld Ultrasound with $220M in FundingExo Looks to Commercialize Its Handheld Ultrasound with $220M in Funding
  • Bruker Announces Acquisition Of Magnettech’s EPR BusinessBruker Announces Acquisition Of Magnettech’s EPR Business

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications